Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Daniel Joseph Apel

CFO at Arrowhead Pharmaceuticals, Inc. (ARWR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $934K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 24SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 3,208172,792 held (−2%) $70.11 $225K -20.3%
Apr 24SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 1,157171,635 held (−1%) $70.45 $82K -20.7%
Apr 24SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 8,730162,905 held (−5%) $71.92 $628K -22.3%
  • Sell

    CFO Daniel Joseph Apel sold $225K of ARWR at $70.11 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Daniel Joseph Apel sold $82K of ARWR at $70.45 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Daniel Joseph Apel sold $628K of ARWR at $71.92 — pre-scheduled 10b5-1 plan sale.